003020.SZ实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 15:04):

Hefei Lifeon Pharmaceutical Co., Ltd. engages research, development, production, and sales of pharmaceutical preparations and an active ingredient (APIs)...

Stats
今日成交量	6.78M
平均成交量	2.22M
市值	3.72B
EPS	CNY0 ( 2024-04-22 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	16.64
ATR14	CNY0.0280 (0.12%)

音量相关性

長: 0.09 (neutral)

短: -0.74 (moderate negative)

Signal:(50.648) Neutral

Hefei Lifeon 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Hefei Lifeon 相关性 - 货币/商品

0.32
( neutral )

0.49
( neutral )

0.00
( neutral )

0.09
( neutral )

0.25
( neutral )

-0.76
( moderate negative )

Hefei Lifeon 财务报表

Annual	2023
营收:	CNY1.88B
毛利润:	CNY943.70M (50.13 %)
EPS:	CNY1.440

FY	2023
营收:	CNY1.88B
毛利润:	CNY943.70M (50.13 %)
EPS:	CNY1.440

FY	2022
营收:	CNY2.58B
毛利润:	CNY964.28M (37.38 %)
EPS:	CNY1.340

FY	2021
营收:	CNY2.27B
毛利润:	CNY907.17M (39.91 %)
EPS:	CNY1.431

Financial Reports:

No articles found.

Hefei Lifeon

Hefei Lifeon Pharmaceutical Co., Ltd. engages research, development, production, and sales of pharmaceutical preparations and an active ingredient (APIs). It offers APIs, such as succimer, urea, paeonol, felodipine, doxazosin mesylate, zofenopril calcium, troxerutin, and sodium 2,3-dimercapto-1-propanesulfonate; medicinal preparations comprising felodipine sustained release tablets, doxazosin mesylate extended-release tablets, melbinum glipizide tablet, yiqihewei capsule, kunning granule, armillariella oral solution, paeonol ointment, urea and vitamin e cream, Kecuo Yintong gel, and Compound Golden Larch bark gel; and plant extracts, including clove oil, evening primrose oil, herba clinopodii P.E, quercetin, and dihydroquercetin. The company also operates retail chain of pharmaceuticals. Hefei Lifeon Pharmaceutical Co., Ltd. was founded in 2002 and is headquartered in Hefei, China.